BennettAFriedmanCAVaneJR. The release prostaglandin E1 from the rat stomach. Nature1967;216:873–6.
2.
WillisAL. Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. J Pharm Pharmacol1969;21:126–8.
3.
SwinsonDRBennettAHamiltonEBD. Synovial prostaglandins in joint disease. Scand J Rheumatol (Suppl)1975;8:26–05.
4.
EakinsKEWhitelockeRAFPerkinsESBennettAUngerWG. Prostaglandin-like activity in ocular inflammation. Br Med J1972;3:452–3.
5.
FerreiraSH. Prostaglandins, aspirin-like drugs and analgesia. Nature New Biol1972;240:200–3.
6.
CrunkhornPWillisAL. Cutaneous reactions to intradermal prostaglandins. Br J Pharmac Chemother1971;41:49–56.
7.
WilliamsTJMorleyJ. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature1973;246:215–17.
8.
WilliamsTJ. Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br Med Bull1983;39:239–42.
9.
BontaILParnhamMJ. Prostaglandins and chronic inflammation. Biochem Pharmacol1978;27:1611–23.
10.
BennettAPosnerJ. Studies on prostaglandin antagonists. Br J Pharmacol1971;42:585–94.
11.
BennettABerryHOsenMEOsenM. Prevention of headache with analgesics. Lancet1978;1:104.
12.
CollierHOJButtNMMcDonald-GibsonWJSaeedSA. Extract of feverfew inhibits prostaglandin biosynthesis. Lancet1980;2:922.
13.
HepinstallSWhiteAWilliamsonLMitchellJRA. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet1985;1:1071–4.
14.
BruneKGrafPRainsfordKD. A pharmacokinetic approach to the understanding of therapeutic and side effects of salicylates. Agents Actions (suppl)1977;1:9–26.
15.
CollinsPOTavaresIABennettA. Inhibition of prostaglandin synthesis by anti-inflammatory drugs in human gastric mucosa. Agents Actions, 1986 in press.
